Processing of High-Yield Biotech Drugs

Biotechnology companies are making significant advances in production of higher concentrations of proteins critical to meeting the demand for life-saving therapies. Despite this advance, production bottlenecks remain because standard filtration technologies lack the ability to perform economically at high flow rates in these high concentration solutions. Pall developed two new filtration technologies that significantly improve production throughput for protein-based biotech drugs. The new Supor UEKV and new Fluorodyne EX high flow sterilizing grade cartridge filters are each unique hybrids that offer the biotech industry cost-effective solutions to processing challenges.